Results 151 to 160 of about 298,377 (234)

Cost-utility analysis of screening and cognitive behavioral therapy compared to usual care for postpartum depression. [PDF]

BMC Psychiatry
Wang B, Shen S, Lok KY, Lin J, Smith RD.
europepmc   +1 more source

Cost-utility analysis of omalizumab for the treatment of chronic spontaneous urticaria in China. [PDF]

Cost Eff Resour Alloc
Huang Y, Yuan H, Huang Z.
europepmc   +1 more source

Pneumococcal Immunization Program: Cost-Utility Analysis for Quebec

Canadian Journal of Infectious Diseases, 1999
Philippe De Wais, Maryse Guay, Jean Drapeau, Carole St-Hilaire, Réjean Hébert, Jacques Pépin, John Spika, Richard Béland   +7 more
doaj   +1 more source

Sentinel Lymph-Node Biopsy Guided Neck Dissection Versus Elective Neck Dissection in the Management of Early-Stage Oral Cancer-A Cost-Utility Analysis. [PDF]

Cancer Med
Thiagarajan S, Sharda S, Chugh Y, Gupta N, Pramesh CS, Prinja S.   +5 more
europepmc   +1 more source

Cosmetic Tourism: A Cost-utility Analysis of Abdominoplasty Performed in the United States and Abroad. [PDF]

Plast Reconstr Surg Glob Open
Mehdizadeh M, Hernandez Alvarez A, Bloom JA, Cordero JJ, Taritsa I, Lee D, Lin SJ.   +6 more
europepmc   +1 more source

Cost-Utility Analysis of TAVI Versus Surgery in Low-Risk Patients with Severe Aortic Stenosis in the UK. [PDF]

Appl Health Econ Health Policy
Curzen N, Candolfi P, MacCarthy P, Lloyd CT, Aetesam-Ur-Rahman M, Bromilow T, Sellitto V, Blackman DJ.   +7 more
europepmc   +1 more source

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study. [PDF]

EClinicalMedicine
Fragoulakis V, Swen JJ, Koufaki MI, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VHM, Dupui M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Manson LEN, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, van der Wouden CH, Dávila-Fajardo CL, Dolžan V, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ, Patrinos GP, Mitropoulou C.   +40 more
europepmc   +1 more source

Pharmacoeconomic evaluation of ICS-LABA therapy in pediatric asthma: a cost-effectiveness and cost-utility analysis. [PDF]

Front Pharmacol
Dai F, Xu J, Xu J, Li W.
europepmc   +1 more source

A cost-utility analysis of Glecaprevir/Pibrentasvir versus Sofosbuvir/Daclatasvir and Sofosbuvir/Velpatasvir for treatment of hepatitis C in Iran. [PDF]

Cost Eff Resour Alloc
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Alavian SM, Pouria A.   +6 more
europepmc   +1 more source

A cost-utility analysis for return-to-work interventions comparing alternative methods for handling missing health-related quality of life data. [PDF]

J Rehabil Med
Nguyen C, Burger EA, Aasdahl L, Morgante N, Fimland MS, Bjørnelv GMW.   +5 more
europepmc   +1 more source